The Cancer Survivors Network (CSN) is a peer support community for cancer patients, survivors, caregivers, families, and friends! CSN is a safe place to connect with others who share your interests and experiences.
SU 11248 (Tyrosine Kinases Inhibitors)
nanuk
CSN Member Posts: 1,358 Member
Comments
-
I am involved in a vaccine trial; the following excerpt is from a web article by a patient who isShandle said:Sorry..I'd like to know more what this is. Are you trying this out?? ~ Wanda
enrolled in a SU 11248. You can read the entire article at:
http://www.healthtalk.com/coloncancer/programs/060904/page02.cfm
"I'm on a clinical trial on a medication called SU11248, which is oral. [I take] one pill a day for 28 days and then two weeks off. Within two weeks, my cough disappeared and my CEA levels started to drop significantly. [My] energy is coming back, and things are getting back to normal - things are looking good. [Medical editor's note: SU11248 is an experimental drug in clinical trials for various cancers. It is designed to interfere with certain proteins called tyrosine kinases. Signals from these tyrosine kinases promote the development and sustain the growth of some cancers."
Discussion Boards
- All Discussion Boards
- 6 Cancer Survivors Network Information
- 6 Welcome to CSN
- 122.6K Cancer specific
- 2.8K Anal Cancer
- 457 Bladder Cancer
- 312 Bone Cancers
- 1.7K Brain Cancer
- 28.6K Breast Cancer
- 407 Childhood Cancers
- 28K Colorectal Cancer
- 4.6K Esophageal Cancer
- 1.2K Gynecological Cancers (other than ovarian and uterine)
- 13.1K Head and Neck Cancer
- 6.4K Kidney Cancer
- 685 Leukemia
- 804 Liver Cancer
- 4.2K Lung Cancer
- 5.1K Lymphoma (Hodgkin and Non-Hodgkin)
- 243 Multiple Myeloma
- 7.2K Ovarian Cancer
- 71 Pancreatic Cancer
- 493 Peritoneal Cancer
- 5.7K Prostate Cancer
- 1.2K Rare and Other Cancers
- 544 Sarcoma
- 744 Skin Cancer
- 661 Stomach Cancer
- 194 Testicular Cancer
- 1.5K Thyroid Cancer
- 5.9K Uterine/Endometrial Cancer
- 6.4K Lifestyle Discussion Boards